Desjardins Global Asset Management’s Gilead Sciences GILD Stock Holding History

Desjardins Global Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$2.27M	Sell	28,072 -94	-0.3%	-$7.32K	0.24%	89
2023 Q3	$2.11M	Buy	28,166 +6,529	+30%	+$502K	0.23%	91
2023 Q2	$1.67M	Buy	21,637 +1,279	+6%	+$102K	0.19%	121
2023 Q1	$1.69M	Buy	20,358 +3,277	+19%	+$271K	0.21%	99
2022 Q4	$1.47M	Buy	17,081 +2,704	+19%	+$214K	0.23%	96
2022 Q3	$886K	Buy	14,377 +139	+1%	+$8.77K	0.11%	173
2022 Q2	$880K	Buy	14,238 +701	+5%	+$43.4K	0.12%	164
2022 Q1	$804K	Buy	13,537 +266	+2%	+$17K	0.07%	211
2021 Q4	$963K	Buy	+13,271	New	+$914K	0.08%	201

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Desjardins Global Asset Management's GILD Position: Q4 2023 in Review

Desjardins Global Asset Management reduced its Gilead Sciences (GILD) stake by 0.33% in Q4 2023, selling an estimated $7.32K and leaving 28,072 shares worth $2.27M. The position accounts for 0.24% of the portfolio, ranked #89.

Desjardins Global Asset Management first reported a position in GILD in Q4 2021 and has held it in 9 quarters since. 1,776 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

Desjardins Global Asset Management held 28,072 shares of Gilead Sciences worth $2.27M as of Q4 2023.
Desjardins Global Asset Management sold 94 Gilead Sciences shares in Q4 2023, an estimated $7.32K.
Gilead Sciences made up 0.24% of Desjardins Global Asset Management's portfolio in Q4 2023, its #89 holding.
Desjardins Global Asset Management first reported a position in Gilead Sciences in Q4 2021 and has held it in 9 quarters since.
1,776 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.